Persantine (Dipyridamole) Drug Information: Uses, Side Effects ...
Dipyridamole is an odorless yellow crystalline powder, having a bitter taste. It is soluble in dilute acids, methanol and chloroform, and practically insoluble in water.
Persantine tablets for oral administration contain:
Active Ingredient TABLETS 25 mg, 50 mg, and 75 mg: dipyridamole
USP 25 mg, 50 mg and 75 mg, respectively.
Inactive Ingredients TABLETS 25 mg, 50 mg, and 75 mg: acacia,
carnauba wax, corn starch, edible white ink, lactose monohydrate, magnesium
stearate, D&C yellow #10 aluminum lake, D&C red #30, helendon aluminum
pink lake, sodium benzoate, methylparaben, propylparaben, polyethylene glycol,
povidone, sucrose, talc, titanium dioxide, and white wax.
Last updated on RxList: 4/18/2008
75 mg Tablets...........................(NDC 0597-0019-01)
STORE AT 25°C (77°F); EXCURSIONS PERMITTED TO 15-30°C (59°-86°F) [SEE USP CONTROLLED ROOM TEMPERATURE]. KEEP OUT OF REACH OF CHILDREN.
Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield,
CT 06877, USA. Licensed from: Boehringer Ingelheim International GmbH, Manufactured
by: Boehringer Ingelheim Promeco, S.A. de C.V. Mexico City, Mexico. Revised
01/21/05. FDA Rev date: 8/1/2005
Last updated on RxList: 4/18/2008
No pharmacokinetic drug-drug interaction studies were conducted with Persantine (dipyridamole USP) Tablets. The following information was obtained from the literature.
Adenosine: Dipyridamole has been reported to increase the plasma
levels and cardiovascular effects of adenosine. Adjustment of adenosine dosage
may be necessary.
Cholinesterase Inhibitors: Dipyridamole may counteract the anticholinesterase
effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia
gravis.
...
Read more...